# Non Inferiority KawasakI Trial With Anakinra

> **NCT06697431** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Meyer Children's Hospital IRCCS** · enrollment: 38 (estimated)

## Conditions studied

- Kawasaki Disease
- Anakinra

## Interventions

- **DRUG:** Anakinra
- **DRUG:** Intravenous Immunoglobulins, Human

## Key facts

- **NCT ID:** NCT06697431
- **Lead sponsor:** Meyer Children's Hospital IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2024-11-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06697431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06697431, "Non Inferiority KawasakI Trial With Anakinra". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06697431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*